Our data demonstrated that Exo-c-Jun-KO attenuates the lung cancer angiogenesis by transferring exosomal miR-494 to recipient endothelial cells (Figure 6), suggesting targeting oncogene c-Jun might be a promising therapeutic approach for lung cancer. The gene discussed is JUN; the disease is lung carcinoma.